Handelsbanken Fonder’s Amphastar Pharmaceuticals AMPH Stock Holding History

Handelsbanken Fonder’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,400	Closed	-$384K	–	1502
2025 Q3	$384K	Hold	14,400	–	–	﹤0.01%	1365
2025 Q2	$331K	Hold	14,400	–	–	﹤0.01%	1397
2025 Q1	$417K	Hold	14,400	–	–	﹤0.01%	1309
2024 Q4	$535K	Sell	14,400 -2,500	-15%	-$114K	﹤0.01%	1256
2024 Q3	$820K	Hold	16,900	–	–	﹤0.01%	1022
2024 Q2	$676K	Buy	16,900 +2,800	+20%	+$116K	﹤0.01%	1018
2024 Q1	$619K	Hold	14,100	–	–	﹤0.01%	1066
2023 Q4	$872K	Buy	14,100 +5,000	+55%	+$263K	﹤0.01%	859
2023 Q3	$419K	Hold	9,100	–	–	﹤0.01%	1134
2023 Q2	$523K	Buy	9,100 +100	+1%	+$4.43K	﹤0.01%	1038
2023 Q1	$338K	Buy	+9,000	New	+$295K	﹤0.01%	1219

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Handelsbanken Fonder's AMPH Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2025, closing a stake of 14,400 shares — an estimated $384K sold.

Handelsbanken Fonder first reported a position in AMPH in Q1 2023 and held it in 11 quarters. The position peaked at $872K in Q4 2023. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

Handelsbanken Fonder reported no remaining Amphastar Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Handelsbanken Fonder sold 14,400 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $384K.
Handelsbanken Fonder first reported a position in Amphastar Pharmaceuticals in Q1 2023 and held it in 11 quarters.
Handelsbanken Fonder's Amphastar Pharmaceuticals position peaked at $872K in Q4 2023.
235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.